Cue Biopharma (CUE) stock
Breakaway doesn't score CUE. It is too small for a fair Quality Score.
Follow CUE's news. Pro members can get an alert when Cue Biopharma files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. 3,170 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.
What's next for CUE, and how long its cash lasts
Next step the company has named
Cash runway
About 4 quarters
Dilution on the horizon
- Shelf registration (S-3, filed Mar 16, 2026)
- At-the-market share sales program (S-3, filed Mar 16, 2026)
Insiders
An officer, Michael Vincent Meluzio, sold 1,144 shares on Oct 12. 5 more insider trades this year.
FDA dates in the next 60 days
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
CUE's latest filings
- Quarterly report
- Cue Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
- 3 insider filings
Why CUE isn't scored
The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. CUE is worth about $34.7M. A stock that clears every mark is scored from the next weekly rebuild.
Straight AnswersStraight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.